INM — InMed Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for InMed Pharmaceuticals, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	R2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5.85	7.41	6.22	8.96	6.61
Net Total Accounts Receivable
Net Total Receivables	0.045	0.012	0.088	0.26	0.353
Total Inventory
Prepaid Expenses
Total Current Assets	6.31	8.38	9.6	11.3	8.69
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.403	0.327	0.904	0.723	1.25
Net Intangible Assets
Other Long Term Assets
Total Assets	7.8	9.78	12.8	14.1	11.8
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.68	2.22	3.32	2	1.97
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.92	2.4	3.71	2.02	2.62
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	5.88	7.38	9.08	12.1	9.21
Total Liabilities & Shareholders' Equity	7.8	9.78	12.8	14.1	11.8
Total Common Shares Outstanding